Sports fans have fantasy baseball. Drug industry analysts have fantasy mergers.
In the pharmaceutical version of the game, analysts use balance sheets to project how big-league drug companies could acquire more nimble rivals. The goal is to enhance product rosters, while reducing costs by shedding redundant staff and operations.
SUBSCRIBE AND FOLLOW
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements.Learn more